ANAB - Anaptys to Present at Guggenheim's 6th Annual Biotechnology Conference | Benzinga
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer, will present at Guggenheim's 6th Annual Biotechnology Conference.
Investor Conference Details
- Event - Guggenheim's 6th Annual Biotechnology Conference
- Format – Fireside chat
- Date and Time – Wednesday, Feb. 7, 2024 at 9:30am ET / 6:30am PT
A live webcast of the fireside chat will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/events. A replay of ...